The “human in the loop” is meant to be a backstop to prevent flawed AI models fr...
A cautionary tale: researchers spent billions of dollars developing gene therapi...
AI-powered summarization tools can save time and angst for hospital staff, but t...
"If we fail, we get up again and again.” After Amylyx ALS trial failure, patient...
Nipocalimab is a monoclonal antibody commercialized by Johnson & Johnson, with a...
Epacadostat is a small molecule commercialized by Incyte, with a leading Phase I...
Cretostimogene Grenadenorepvec is an oncolytic virus commercialized by Kissei P...
Denecimig is a monoclonal antibody commercialized by Novo Nordisk, with a leadin...
Rilvegostomig is a monoclonal antibody commercialized by AstraZeneca, with a lea...
(Insulin icodec + Semaglutide) is a recombinant peptide and recombinant protein ...
Belcesiran is an antisense rnai oligonucleotide commercialized by Novo Nordisk, ...
Saruparib is a small molecule commercialized by AstraZeneca, with a leading Phas...
AZD-3427 is commercialized by AstraZeneca, with a leading Phase II program in P...
PN-235 is a synthetic peptide commercialized by Johnson & Johnson, with a leadin...
Eli Lilly’s recent breakthrough in eczema treatment represents a stride in addre...
In its pursuit of Regeneron and Sanofi’s Dupixent in the treatment of prurigo no...
